Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

World Opioid-Induced Constipation Market Research Report 2026 (Covering USA, Europe, China, Japan, India and etc)

  • ICR4609252
  • 110 Pages
  • August 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

ICRWorld’s Opioid-Induced Constipation market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.

The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

Global Opioid-Induced Constipation Market: Product Segment Analysis

Methylnaltrexone Bromide

Lubiprostone

Naloxegol

Global Opioid-Induced Constipation Market: Application Segment Analysis

Hospital

Pharmacy

Global Opioid-Induced Constipation Market: Regional Segment Analysis

USA

Europe

Japan

China

India

South East Asia

The Players mentioned in our report

Takeda Pharmaceuticals

Bayer

Mallinckrodt

Salix (Bausch Health)

AstraZeneca

Progenics Pharmaceuticals

Purdue Pharm

Nektar Therapeutics

Daiichi Sankyo

Sanofi

Prestige

GSK

Shionogi

Table of Content

Chapter 1 About the Opioid-Induced Constipation Industry

1.1 Industry Definition and Types

1.1.1 Methylnaltrexone Bromide

1.1.2 Lubiprostone

1.1.3 Naloxegol

1.2 Main Market Activities

1.3 Similar Industries

1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape

2.1 Opioid-Induced Constipation Markets by Regions

2.1.1 USA

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.1.2 Europe

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.1.3 China

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.1.4 India

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.1.5 Japan

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.1.6 South East Asia

Market Revenue (M USD) and Growth Rate 2016-2021

Sales and Growth Rate 2016-2021

Major Players

2.2 World Opioid-Induced Constipation Market by Types

Methylnaltrexone Bromide

Lubiprostone

Naloxegol

2.3 World Opioid-Induced Constipation Market by Applications

Hospital

Pharmacy

2.4 World Opioid-Induced Constipation Market Analysis

2.4.1 World Opioid-Induced Constipation Market Revenue and Growth Rate 2016-2021

2.4.2 World Opioid-Induced Constipation Market Consumption and Growth rate 2016-2021

2.4.3 World Opioid-Induced Constipation Market Price Analysis 2016-2021

Chapter 3 World Opioid-Induced Constipation Market share

3.1 Major Production Market share by Players

3.2 Major Revenue (M USD) Market share by Players

3.3 Major Production Market share by Regions in 2021, Through 2026

3.4 Major Revenue (M USD) Market share By Regions in 2021, Through 2026

Chapter 4 Supply Chain Analysis

4.1 Industry Supply chain Analysis

4.2 Raw material Market Analysis

4.2.1 Raw material Prices Analysis 2016-2021

4.2.2 Raw material Supply Market Analysis

4.2 Manufacturing Equipment Suppliers Analysis

4.3 Production Process Analysis

4.4 Production Cost Structure Benchmarks

4.5 End users Market Analysis

Chapter 5 Company Profiles

5.1 Takeda Pharmaceuticals

5.1.1 Company Details (Foundation Year, Employee Strength and etc)

5.1.2 Product Information (Picture, Specifications and Applications)

5.1.3 Revenue (M USD), Price and Operating Profits

5.2 Bayer

5.2.1 Company Details (Foundation Year, Employee Strength and etc)

5.2.2 Product Information (Picture, Specifications and Applications)

5.2.3 Revenue (M USD), Price and Operating Profits

5.3 Mallinckrodt

5.3.1 Company Details (Foundation Year, Employee Strength and etc)

5.3.2 Product Information (Picture, Specifications and Applications)

5.3.3 Revenue (M USD), Price and Operating Profits

5.4 Salix (Bausch Health)

5.4.1 Company Details (Foundation Year, Employee Strength and etc)

5.4.2 Product Information (Picture, Specifications and Applications)

5.4.3 Revenue (M USD), Price and Operating Profits

5.5 AstraZeneca

5.5.1 Company Details (Foundation Year, Employee Strength and etc)

5.5.2 Product Information (Picture, Specifications and Applications)

5.5.3 Revenue (M USD), Price and Operating Profits

5.6 Progenics Pharmaceuticals

5.6.1 Company Details (Foundation Year, Employee Strength and etc)

5.6.2 Product Information (Picture, Specifications and Applications)

5.6.3 Revenue (M USD), Price and Operating Profits

5.7 Purdue Pharm

5.7.1 Company Details (Foundation Year, Employee Strength and etc)

5.7.2 Product Information (Picture, Specifications and Applications)

5.7.3 Revenue (M USD), Price and Operating Profits

5.8 Nektar Therapeutics

5.8.1 Company Details (Foundation Year, Employee Strength and etc)

5.8.2 Product Information (Picture, Specifications and Applications)

5.8.3 Revenue (M USD), Price and Operating Profits

5.9 Daiichi Sankyo

5.9.1 Company Details (Foundation Year, Employee Strength and etc)

5.9.2 Product Information (Picture, Specifications and Applications)

5.9.3 Revenue (M USD), Price and Operating Profits

5.10 Sanofi

5.10.1 Company Details (Foundation Year, Employee Strength and etc)

5.10.2 Product Information (Picture, Specifications and Applications)

5.10.3 Revenue (M USD), Price and Operating Profits

5.11 Prestige

5.11.1 Company Details (Foundation Year, Employee Strength and etc)

5.11.2 Product Information (Picture, Specifications and Applications)

5.11.3 Revenue (M USD), Price and Operating Profits

5.12 GSK

5.12.1 Company Details (Foundation Year, Employee Strength and etc)

5.12.2 Product Information (Picture, Specifications and Applications)

5.12.3 Revenue (M USD), Price and Operating Profits

5.13 Shionogi

5.13.1 Company Details (Foundation Year, Employee Strength and etc)

5.13.2 Product Information (Picture, Specifications and Applications)

5.13.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade

6.1 Business Locations

6.2 Supply channels

6.3 Marketing strategy

6.4 Barriers to Entry

Chapter 7 Distributors and Customers

7.1 Major Distributors and contact information by Regions

7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries

8.1 USA

8.2 Germany

8.3 China

8.4 Japan

8.5 India

Chapter 9 World Opioid-Induced Constipation Market Forecast through 2026

9.1 World Opioid-Induced Constipation Demand by Regions Forecast through 2026

9.2 World Opioid-Induced Constipation Price(by Regions, Types, Applications)Analysis Forecast through 2026

9.3 World Opioid-Induced Constipation Revenue (M USD)(by Regions, Types, Applications) Forecast through 2026

9.4 World Opioid-Induced Constipation Market Analysis

9.4.1 World Opioid-Induced Constipation Market Revenue and Growth Rate 2016-2021

9.4.2 World Opioid-Induced Constipation Market Consumption and Growth rate 2016-2021

9.4.3 World Opioid-Induced Constipation Market Price Analysis 2016-2021

Chapter 10 Key success factors and Market Overview

Tables and figures

Table Main Market Activities by Regions

Table Market Revenue (M USD) and Growth Rate 2016-2021

Table Major Players

Table Market Revenue (M USD) and Growth Rate 2016-2021

Table Major Players

Table Market Revenue (M USD) and Growth Rate 2016-2021

Table Major Players

Table Market Revenue (M USD) and Growth Rate 2016-2021

Table Major Players

Table Market Revenue (M USD) and Growth Rate 2016-2021

Table Major Players

Table Major Production Market share by Players 2020

Table Major Revenue (M USD) Market share by Players 2020

Table Production Market share by Major Regions in 2016-2021

Table Production Market share by Major Regions in 2021-2026

Table Revenue (M USD) Market share by Regions in 2016-2021

Table Revenue (M USD) Market share by Regions in 2021-2026

Table Industry Supply chain Analysis

Table Raw material Prices Analysis 2016-2021

Table Raw material Suppliers Market Analysis

Table Manufacturing Equipment Suppliers Analysis

Figure Production Process Analysis

Figure Production Cost Structure

Table major End Users by Regions

Table Takeda Pharmaceuticals Information List

Figure Opioid-Induced ConstipationOpioid-Induced Constipation Picture, Specifications and Applications of Takeda Pharmaceuticals

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Takeda Pharmaceuticals 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Takeda Pharmaceuticals 2020-2021

Table Bayer Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Bayer

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bayer 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Bayer 2020-2021

Table Mallinckrodt Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Mallinckrodt

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Mallinckrodt 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Mallinckrodt 2020-2021

Table Salix (Bausch Health) Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Salix (Bausch Health)

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Salix (Bausch Health) 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Salix (Bausch Health) 2020-2021

Table AstraZeneca Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of AstraZeneca

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of AstraZeneca 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of AstraZeneca 2020-2021

Table Progenics Pharmaceuticals Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Progenics Pharmaceuticals

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Progenics Pharmaceuticals 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Progenics Pharmaceuticals 2020-2021

Table Purdue Pharm Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Purdue Pharm

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Purdue Pharm 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Purdue Pharm 2020-2021

Table Nektar Therapeutics Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Nektar Therapeutics

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Nektar Therapeutics 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Nektar Therapeutics 2020-2021

Table Daiichi Sankyo Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Daiichi Sankyo

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Daiichi Sankyo 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Daiichi Sankyo 2020-2021

Table Sanofi Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Sanofi

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Sanofi 2020-2021

Table Prestige Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Prestige

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Prestige 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Prestige 2020-2021

Table GSK Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of GSK

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GSK 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of GSK 2020-2021

Table Shionogi Information List

Figure Opioid-Induced Constipation Picture, Specifications and Applications of Shionogi

Table Opioid-Induced Constipation Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Shionogi 2020-2021

Figure Opioid-Induced Constipation Sales Volume and World Market Share of Shionogi 2020-2021

Table Business Locations

Figure Supply channels

Figure Marketing strategy

Table Barriers Analysis to Entry

Table Major Distributors and contact information by Regions

Table Major Customers and contact information by Regions

Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)

Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)

Table China Supply, Import, Export, Consumption and Consumption Value(M USD)

Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)

Table India Supply, Import, Export, Consumption and Consumption Value(M USD)

Table World Demand by Regions Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Price by Regions Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Price by Types Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Price by Applications Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Revenue (M USD) by Regions Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Revenue (M USD) by Types Forecast Analysis of Opioid-Induced Constipation (2021-2026)

Table World Revenue (M USD) by Applications Forecast Analysis of Opioid-Induced Constipation (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390